Correlation
The correlation between MCY and BMY is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
MCY vs. BMY
Compare and contrast key facts about Mercury General Corporation (MCY) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MCY or BMY.
Performance
MCY vs. BMY - Performance Comparison
Loading data...
Key characteristics
MCY:
0.20
BMY:
0.59
MCY:
0.38
BMY:
1.00
MCY:
1.06
BMY:
1.12
MCY:
0.08
BMY:
0.34
MCY:
0.16
BMY:
1.82
MCY:
19.77%
BMY:
8.95%
MCY:
40.71%
BMY:
31.46%
MCY:
-68.83%
BMY:
-70.62%
MCY:
-23.53%
BMY:
-35.79%
Fundamentals
MCY:
$3.31B
BMY:
$95.34B
MCY:
$5.16
BMY:
$2.68
MCY:
11.58
BMY:
17.48
MCY:
1.19
BMY:
2.26
MCY:
0.59
BMY:
2.00
MCY:
1.82
BMY:
5.48
MCY:
$5.60B
BMY:
$47.64B
MCY:
-$1.20B
BMY:
$31.43B
MCY:
$350.32M
BMY:
$16.18B
Returns By Period
In the year-to-date period, MCY achieves a -9.57% return, which is significantly higher than BMY's -15.35% return. Over the past 10 years, MCY has outperformed BMY with an annualized return of 5.26%, while BMY has yielded a comparatively lower -0.44% annualized return.
MCY
-9.57%
10.87%
-22.36%
6.96%
11.32%
13.19%
5.26%
BMY
-15.35%
-2.19%
-18.54%
19.19%
-11.84%
-1.54%
-0.44%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MCY vs. BMY — Risk-Adjusted Performance Rank
MCY
BMY
MCY vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Mercury General Corporation (MCY) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MCY vs. BMY - Dividend Comparison
MCY's dividend yield for the trailing twelve months is around 2.13%, less than BMY's 5.21% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCY Mercury General Corporation | 2.13% | 1.91% | 3.41% | 5.57% | 4.78% | 4.83% | 5.16% | 4.84% | 4.67% | 4.12% | 5.31% | 4.35% |
BMY Bristol-Myers Squibb Company | 5.21% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
MCY vs. BMY - Drawdown Comparison
The maximum MCY drawdown since its inception was -68.83%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for MCY and BMY.
Loading data...
Volatility
MCY vs. BMY - Volatility Comparison
The current volatility for Mercury General Corporation (MCY) is 9.42%, while Bristol-Myers Squibb Company (BMY) has a volatility of 11.41%. This indicates that MCY experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MCY vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Mercury General Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MCY vs. BMY - Profitability Comparison
MCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mercury General Corporation reported a gross profit of -7.19M and revenue of 1.39B. Therefore, the gross margin over that period was -0.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a gross profit of 8.17B and revenue of 11.20B. Therefore, the gross margin over that period was 72.9%.
MCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mercury General Corporation reported an operating income of -142.30M and revenue of 1.39B, resulting in an operating margin of -10.2%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported an operating income of 3.52B and revenue of 11.20B, resulting in an operating margin of 31.4%.
MCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mercury General Corporation reported a net income of -108.33M and revenue of 1.39B, resulting in a net margin of -7.8%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a net income of 2.46B and revenue of 11.20B, resulting in a net margin of 21.9%.